Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure
NIDA - National Institute on Drug Abuse
About This Grant
Cannabis use during pregnancy has increased substantially, in conjunction with widespread decriminalization/legalization, changing public perceptions about harm, and evidence of cannabis’s antiemetic properties. Prior outcomes research on prenatal cannabis exposure is narrow in scope, as these older studies included research participants with polysubstance use (e.g., tobacco, alcohol, illicit drugs). In addition, prior research likely underestimated potential risks specific to cannabis use during pregnancy because modern strains are 10x more potent than they were 40 years ago. In our currently funded research, cannabis use is measured prospectively during pregnancy using weekly reports validated with labels and urine-based assays. Infants receive a neonatal neurobehavioral exam and multi-modal imaging (functional magnetic resonance imaging, myelin imaging, diffusion tensor imaging, and structural MRI) under natural sleep at 2-4 weeks-of-age and extensive neuropsychological follow-up assessments at 6 and 18 months. We propose to broaden the impact of this work by collecting longitudinal MRI scans concurrently with the 6- and 18-month neuropsychological visits. By focusing on the first 18 months of life, we aim to characterize cannabis-induced brain changes and dysregulated growth trajectories at a time when rapid synaptogenesis, axonal growth, and myelination is unfolding. In addition, we will test the hypothesis that prenatal cannabis exposure is more detrimental to females than males. This program of research aims to clarify potential health risks, enabling the general public to make better-informed choices surrounding cannabis use during pregnancy.
Grant Summary
Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure is a NIDA - National Institute on Drug Abuse grant providing up to $700K for university, nonprofit, healthcare org. Applications are due 2030-11-30 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $700K
2030-11-30
- 1Confirm your organization is eligible for Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure from NIDA - National Institute on Drug Abuse, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIDA - National Institute on Drug Abuse before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIDA - National Institute on Drug Abuse's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure: Frequently Asked Questions
Who is eligible for the Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure?
Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure is offered by NIDA - National Institute on Drug Abuse and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure provide?
Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure provides up to $700K per award from NIDA - National Institute on Drug Abuse. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure deadline?
Applications for Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure are due 2030-11-30 (open). Because deadlines can change, verify the date with the funder, NIDA - National Institute on Drug Abuse, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure?
To apply for Neurodevelopmental Trajectories Associated with Prenatal Cannabis Exposure, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIDA - National Institute on Drug Abuse.